CIRAD Agricultural research for devlopement
  • Version française
  • Intranet
Quick search
  • News
  • Jobs
  • Directory/Access
  • Who are we?
    • In a nutshell
    • Our mandate
    • Our strategy
    • Our partnerships
    • CIRAD worldwide
    • Our values
  • Research operations
    • Priority lines of research
    • Research Topics
    • Supply chains
    • Research units
    • Collective research tools
    • Research results
  • Teaching & training
    • PhD training
    • Higher education
    • Available training
    • Scientific experience
    • E-learning
    • Grants
  • Innovation & expertise
    • Partnerships for innovation
    • Skills and expertise
    • Products and services
    • Technology transfer
    • The CIRAD VIP newsletter
  • Publications & resources
    • Documentary resources
    • Publications
    • Science for all
    • Vidéos
    • Website Directory
  • You are here:
  • Home >
  • Innovation & expertise >
  • Technology transfer >
  • Processes >
  • Overproduction of albicidin

Back to the list
Transformed Xanthomonas axonopodis pv. vesicatoria strain that produces an antibiotic active against Escherichia coli.

Contact

Cirad
BGPI Research Unit,
TA 70/09,
34398 Montpellier
Cedex 5, France
Tel : 33 (0)4 67 61 65 92
Fax: 33 (0)4 67 61 71 60
E-mail 1
E-mail 2
E-mail 3

  • Partnerships for innovation
  • Skills and expertise
  • Products and services
  • Technology transfer
    • Processes
  • The CIRAD VIP newsletter

Overproduction of albicidin

Albicidin is a strong antibiotic produced by a bacterium that affects sugarcane, Xanthomonas albilineans.

Albicidin is a broad-spectrum antibiotic. In particular, it is highly active against Escherichia coli , a bacterial species involved in certain hospital-acquired "superbugs". CIRAD and the University of Florida have developed a way of biosynthesizing albicidin in a fast-growing bacterium, Xanthomonas axonopodis pv. vesicatoria .

Main advantages

  • The process enables the production of much greater quantities of albicidin than in Xanthomonas albilineans.
  • It will enable the production and purification of sufficient quantities of albicidin to characterize its structure and chemical composition.
  • Albicidin yields are optimized.
  • The albicidin molecule is a complex polyketide that does not resemble any other antibiotic. Determining its structure will pave the way for a new family of antibiotics.
  • Producing large quantities of albicidin will enable an exploration of all the possible applications of this new polyketide.

Intellectual rights

Patented process.

Partnership kind

This process, for producing a broad-spectrum antibiotic, is primarily of interest to the pharmaceuticals industry. CIRAD has the necessary skills to optimize the production system. It is looking for partners interested in promoting the process.


  • © CIRAD 2009
  • Site map
  • RSS feed
  • Legal details
  • Public procurement